Novel drug candidate could treat visceral leishmaniasis
Collaborative research between the University of Dundee, GSK and Wellcome has uncovered a new preclinical drug candidate that could treat one of the world’s major neglected diseases.
Please sign in or register for FREE
Sign in to RxNet
Register to RxNet
RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.